Article Versions Notes

Altendorf T, Gering I, Santiago-Schübel B, Aghabashlou Saisan S, Tamgüney G, Tusche M, Honold D, Schemmert S, Hoyer W, Mohrlüder J, et al. Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer’s Disease and Other Tauopathies. International Journal of Molecular Sciences. 2023; 24(3):2161. https://doi.org/10.3390/ijms24032161

Altendorf, Tim, Ian Gering, Beatrix Santiago-Schübel, Selma Aghabashlou Saisan, Gültekin Tamgüney, Markus Tusche, Dominik Honold, Sarah Schemmert, Wolfgang Hoyer, Jeannine Mohrlüder, and et al. 2023. "Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer’s Disease and Other Tauopathies" International Journal of Molecular Sciences 24, no. 3: 2161. https://doi.org/10.3390/ijms24032161

Altendorf, T., Gering, I., Santiago-Schübel, B., Aghabashlou Saisan, S., Tamgüney, G., Tusche, M., Honold, D., Schemmert, S., Hoyer, W., Mohrlüder, J., & Willbold, D. (2023). Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer’s Disease and Other Tauopathies. International Journal of Molecular Sciences, 24(3), 2161. https://doi.org/10.3390/ijms24032161